Selecting Cytoreductive Therapy for Patients with PV or ET

Video

Laura Michaelis, MD, discusses how to select patients with either polycythemia vera or essential thrombocythemia for cytoreductive therapy.

Laura Michaelis, MD, associate professor of medicine, Medical College of Wisconsin, discusses how to select patients with either polycythemia vera (PV) or essential thrombocythemia (ET) for cytoreductive therapy.

According to Michaelis, if a patient with PV is over the age of 60 or has had a prior arterial or venous clot, she will give these patients cytoreductive treatment. However, she does not treat patients with ET the same way.

Related Videos
Related Content